PL2504698T3 - Sposób przewidywania odpowiedzi choroby nowotworowej na środek terapeutyczny - Google Patents
Sposób przewidywania odpowiedzi choroby nowotworowej na środek terapeutycznyInfo
- Publication number
- PL2504698T3 PL2504698T3 PL10787078T PL10787078T PL2504698T3 PL 2504698 T3 PL2504698 T3 PL 2504698T3 PL 10787078 T PL10787078 T PL 10787078T PL 10787078 T PL10787078 T PL 10787078T PL 2504698 T3 PL2504698 T3 PL 2504698T3
- Authority
- PL
- Poland
- Prior art keywords
- predicting
- response
- tumour disease
- therapeutic measure
- therapeutic
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Physiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE200910047146 DE102009047146B4 (de) | 2009-11-25 | 2009-11-25 | Verfahren zum Vorhersagen des Ansprechens einer Tumorerkrankung auf eine therapeutische Maßnahme |
| EP10787078.4A EP2504698B1 (de) | 2009-11-25 | 2010-11-25 | Verfahren zum vorhersagen des ansprechens einer tumorerkrankung auf eine therapeutische massnahme |
| PCT/EP2010/068235 WO2011064308A1 (de) | 2009-11-25 | 2010-11-25 | Verfahren zum vorhersagen des ansprechens einer tumorerkrankung auf eine therapeutische massnahme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2504698T3 true PL2504698T3 (pl) | 2018-10-31 |
Family
ID=43413696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10787078T PL2504698T3 (pl) | 2009-11-25 | 2010-11-25 | Sposób przewidywania odpowiedzi choroby nowotworowej na środek terapeutyczny |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2504698B1 (pl) |
| JP (1) | JP5926187B2 (pl) |
| CA (1) | CA2781727C (pl) |
| DE (1) | DE102009047146B4 (pl) |
| DK (1) | DK2504698T3 (pl) |
| ES (1) | ES2673514T3 (pl) |
| HR (1) | HRP20180906T1 (pl) |
| HU (1) | HUE037770T2 (pl) |
| PL (1) | PL2504698T3 (pl) |
| PT (1) | PT2504698T (pl) |
| SI (1) | SI2504698T1 (pl) |
| TR (1) | TR201808349T4 (pl) |
| WO (1) | WO2011064308A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102012213838A1 (de) * | 2012-08-03 | 2014-02-06 | Katharina Pachmann | Verfahren zur Kultivierung einer Subpopulation zirkulierender epithelialer Tumorzellen aus einer Körperflüssigkeit |
| DE102013010528B3 (de) * | 2013-06-25 | 2014-02-20 | FLACOD GmbH | Verfahren zur Erstellung einer Datenbank für die Vorabschätzung der Wirksamkeit von Wirkstoffen in der Tumortherapie |
| GB201507894D0 (en) | 2015-05-08 | 2015-06-24 | Imagen Biotech Ltd | Personalised media |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19833738A1 (de) | 1998-07-27 | 2000-02-03 | Michael Giesing | Verfahren zur Isolierung von Krebszellen aus zellhaltigen Körperflüssigkeiten sowie Sets zur Durchführung dieses Verfahrens |
| BR0207290A (pt) | 2001-02-16 | 2005-06-07 | Immunivest Corp | Método para analisar um paciente quanto à presença de uma malignidade, célula maligna isolada das células cultivadas, vacina de tumor, molécula associada com diátese de tumor alterada, métodos para determinar alterações em moléculas associadas com diátese de tumor como um meio para predizer a eficácia da terapia, como um meio para analisar dosagem apropriada para terapia, como um meio para monitorar eficácia da terapia, como um meio para analisar progressão de câncer, para realizar uma biópsia de corpo inteiro em um paciente, e para identificar alterações em uma célula de tumor circulante relativamente a células presentes numa massa de tumor in situ, e, kit de teste para analisar uma amostra de paciente quanto à presença de uma célula maligna não-hematopoiética |
| WO2007035842A2 (en) | 2005-09-21 | 2007-03-29 | Ccc Diagnostics, Llc | Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy (pac) |
-
2009
- 2009-11-25 DE DE200910047146 patent/DE102009047146B4/de active Active
-
2010
- 2010-11-25 WO PCT/EP2010/068235 patent/WO2011064308A1/de not_active Ceased
- 2010-11-25 TR TR2018/08349T patent/TR201808349T4/tr unknown
- 2010-11-25 HR HRP20180906TT patent/HRP20180906T1/hr unknown
- 2010-11-25 ES ES10787078.4T patent/ES2673514T3/es active Active
- 2010-11-25 PT PT107870784T patent/PT2504698T/pt unknown
- 2010-11-25 HU HUE10787078A patent/HUE037770T2/hu unknown
- 2010-11-25 PL PL10787078T patent/PL2504698T3/pl unknown
- 2010-11-25 DK DK10787078.4T patent/DK2504698T3/en active
- 2010-11-25 EP EP10787078.4A patent/EP2504698B1/de active Active
- 2010-11-25 CA CA2781727A patent/CA2781727C/en active Active
- 2010-11-25 JP JP2012540434A patent/JP5926187B2/ja active Active
- 2010-11-25 SI SI201031705T patent/SI2504698T1/sl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013511968A (ja) | 2013-04-11 |
| SI2504698T1 (sl) | 2018-09-28 |
| HRP20180906T1 (hr) | 2018-08-24 |
| PT2504698T (pt) | 2018-06-20 |
| CA2781727A1 (en) | 2011-06-03 |
| DE102009047146B4 (de) | 2012-07-19 |
| ES2673514T3 (es) | 2018-06-22 |
| EP2504698A1 (de) | 2012-10-03 |
| CA2781727C (en) | 2018-06-05 |
| DE102009047146A1 (de) | 2011-06-01 |
| WO2011064308A1 (de) | 2011-06-03 |
| EP2504698B1 (de) | 2018-03-14 |
| TR201808349T4 (tr) | 2018-07-23 |
| HUE037770T2 (hu) | 2018-09-28 |
| DK2504698T3 (en) | 2018-06-18 |
| JP5926187B2 (ja) | 2016-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276487B (en) | Methods for predicting clinical outcome of cancer | |
| IL209855A0 (en) | Supression of neuroedocrine diseases | |
| ZA201206019B (en) | Methods for predicting response of triple-negative breast cancer to therapy | |
| IL214919A0 (en) | Method for therapeutic use | |
| ZA201302519B (en) | Process for making multiparticulate gastroretentive dosage forms | |
| EP2649456A4 (en) | BIOMARKERS FOR MONITORING THE TREATMENT OF NEUROPSYCHIATRIC ILLNESSES | |
| EP2601954A4 (en) | THERAPEUTIC FOR DISEASES | |
| IL218320A0 (en) | Therapeutic agent for anxiety disorders | |
| SI2504698T1 (sl) | Postopek za napovedovanje odziva tumorskega obolenja na terapevtski ukrep | |
| ZA201105271B (en) | Soluble icam-1 as biomarker for prediction of therapeutic response | |
| DK2419728T3 (da) | Biomarkør til at overvåge patienter | |
| HUP1100131A2 (en) | Diagnosis of systemic diseases | |
| GB0903858D0 (en) | Diagnosis of disease | |
| PT2526422T (pt) | Método de diagnóstico da doença de sjögren | |
| AP2013006853A0 (en) | Biomarker for vavular heart disease | |
| TWM365744U (en) | Walking aided apparatus structure | |
| GB0906026D0 (en) | Therapeutic compounds | |
| GB201019936D0 (en) | Therapeutic method | |
| GB0919114D0 (en) | Therapeutic intervention | |
| GB201004773D0 (en) | Improvements relating to support for therapeutic postures | |
| GB0911266D0 (en) | Therapeutic compounds | |
| GB0900712D0 (en) | Therapeutic compounds | |
| GB0916608D0 (en) | Therapeutic compounds | |
| GB0916308D0 (en) | Therapeutic compounds | |
| EP2533683A4 (en) | METHOD OF CHARACTERIZING PATHOLOGICAL RESPONSE OF TISSUE TO TREATMENT |